Valuation (81%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.90 | N/A |
| PEG Ratio (TTM) | 0.10 | N/A |
| P/S Ratio (TTM) | 11.31 | N/A |
| P/B Ratio (TTM) | 0.86 | N/A |
| P/FCF Ratio (TTM) | 12.50 | N/A |
| Price to 5YR AVG Earnings Ratio | 23.19 | N/A |
| Price to 5YR AVG FCF Ratio | 4.16 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.91% | N/A |
| ROE (TTM) | 3.21% | N/A |
| Net Profit Margin (TTM) | 42.06% | N/A |
| ROIC 5YR AVG | 2.23% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 59.84% | 34.96% | -12.87% |
| Revenue | -11.02% | 34.12% | -11.39% |
| Net Income | 34.99% | 227.96% | 103.01% |
| Cash Flow | 234.87% | 1,179.35% | 689.16% |
Health (26%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.07 | N/A |
| Quick Ratio (TTM) | 0.07 | N/A |
| D/E Ratio (TTM) | 0.65 | N/A |
| Interest Coverage (TTM) | 3.54 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.11 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 76.61% | N/A |